August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of Manasquan, N.J., which now offers amyvid positron emission tomography (PET) scans to identify the presence of plaque in the brain.
Amyvid (florbetapir F-18 injection) is indicated for PET imaging of the brain to estimate beta-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.
“Current AD medications and management strategies can temporarily improve symptoms, maximize function and maintain independence, and we are pleased that our Attrius PET system could possibly help with the identification and management of this disease,” said Joseph Oliverio, chief technology officer and director of PET clinical programs at Positron.
Said Lorraine Catalano, imaging director at Caring Heart: “Alzheimer’s disease can now be diagnosed several years before the onset of symptoms. Early detection can lead to innovative programs designed to treat memory loss. This alternative can make the difference between a life of constant hardship or one that is fulfilled and remains on top of its game.”
For more information: www.positron.com, www.chci.biz
October 19, 2026 
